RE:RE:RE:RE:Good News I think it's because of this part in the NEWS;
MONTREAL, March 9, 2016 /CNW Telbec/ - Telesta Therapeutics Inc. (TSX:TST)(PNK:BNHLF) today announced that it has submitted a request to meet with the U.S. Food and Drug Administration (FDA). This "Type A" meeting request includes specific questions concerning the regulatory path forward for Telesta's therapeutic MCNA1 in the United States. Telesta expects, based on FDA guidance, that the meeting or teleconference (at the FDA's discretion) will be held within 30 calendar days. Telesta's objective is to obtain clarity on what the FDA will require to consider commercial approval of MCNA for high-risk non-muscle invasive bladder cancer patients who have failed front-line BCG therapy.
Read more at https://www.stockhouse.com/news/press-releases/2016/03/09/telesta-therapeutics-provides-corporate-update#Jrc4zgD3MDZykmek.99